- Home
- IBOC vs ICUI Comparison
IBOC vs ICUI Comparison
Compare IBOC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBOC
- ICUI
- Stock Information
- Founded
- IBOC 1966
- ICUI 1984
- Country
- IBOC United States
- ICUI United States
- Employees
- IBOC N/A
- ICUI N/A
- Industry
- IBOC Major Banks
- ICUI Medical/Dental Instruments
- Sector
- IBOC Finance
- ICUI Health Care
- Exchange
- IBOC Nasdaq
- ICUI Nasdaq
- Market Cap
- IBOC 4.5B
- ICUI 3.8B
- IPO Year
- IBOC N/A
- ICUI 1992
- Fundamental
- Price
- IBOC $66.82
- ICUI $160.99
- Analyst Decision
- IBOC
- ICUI Buy
- Analyst Count
- IBOC 0
- ICUI 4
- Target Price
- IBOC N/A
- ICUI $199.67
- AVG Volume (30 Days)
- IBOC 303.6K
- ICUI 206.7K
- Earning Date
- IBOC 02-24-2025
- ICUI 02-25-2025
- Dividend Yield
- IBOC 2.00%
- ICUI N/A
- EPS Growth
- IBOC N/A
- ICUI N/A
- EPS
- IBOC 6.43
- ICUI N/A
- Revenue
- IBOC $799,362,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- IBOC N/A
- ICUI $4.38
- Revenue Next Year
- IBOC N/A
- ICUI $0.34
- P/E Ratio
- IBOC $10.10
- ICUI N/A
- Revenue Growth
- IBOC 0.95
- ICUI 4.04
- 52 Week Low
- IBOC $48.85
- ICUI $87.65
- 52 Week High
- IBOC $76.91
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- IBOC 54.07
- ICUI 45.68
- Support Level
- IBOC $63.30
- ICUI $155.00
- Resistance Level
- IBOC $68.09
- ICUI $173.85
- Average True Range (ATR)
- IBOC 1.59
- ICUI 5.93
- MACD
- IBOC 0.19
- ICUI -0.72
- Stochastic Oscillator
- IBOC 73.49
- ICUI 29.21
About IBOC International Bancshares Corporation
International Bancshares Corp is a multibank financial holding company. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.